Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders
BackgroundsIntramuscular injection of the SARS-CoV-2 vaccine has raised concerns about its use in patients with neuromuscular disorders (NMDs). We evaluated the response of patients with NMDs to the BNT162b2 vaccine.MethodsHealthy subjects, patients with spinal muscular atrophy (SMA), and patients w...
Main Authors: | Hideyuki Iwayama, Naoko Ishihara, Kohei Kawahara, Yuta Madokoro, Yasuko Togawa, Kanji Muramatsu, Ayuka Murakami, Satoshi Kuru, Toshiyuki Kumagai, Wataru Ohashi, Kengo Nanya, Shinji Hasegawa, Masahisa Katsuno, Akihisa Okumura |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.996134/full |
Similar Items
-
Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
by: van Westering, T
Published: (2018) -
Exercise attenuates polyglutamine‐mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophy
by: Tomoki Hirunagi, et al.
Published: (2024-02-01) -
Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al. -
A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01) -
The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)